These results suggested that breast cancer patients with PIK3CA exon 9 mutation had the best prognosis, while patients with PIK3CA exon 20 mutation had lower DFS than those with wild type, but the difference was not statistically significant (χ2 = 0.347, p > 0.05). The gene discussed is PIK3CA; the disease is breast cancer.